ASX Code | VTI1 |
Website | N/A |
Industry/Sector | Health Care Supplies |
Market Cap ($M) | n/a |
VTI1 Share Price | N/A |
Day High | N/A |
Day Low | N/A |
Last Close | N/A |
VTI1 Share Price Movement | N/A |
There are no dividends for Virotec International Limited (VTI1). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
There are no announcements from Virotec International Limited (VTI1). Please use our ASX Announcements tool to search for announcements across all ASX-listed securities.
Name | Position | Start Date |
---|---|---|
Mr Brian Sheeran | Chairman | 1 Jan 0001 |
Mr John Robert Catling | Chief Executive Officer | 4 Oct 2005 |
Mr Bruno Bamonte | Finance Director | 1 Jan 0001 |
Dr David McConchie | Non-Executive Director | 1 Jan 0001 |
Mr John Glynn | Non-Executive Director | 1 Jan 0001 |
There are no directors' trades from Virotec International Limited (VTI1). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
Name | Position |
---|---|
Angus Craig | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (VTI1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
Holding | Name |
---|---|
14,768,000 (6.20%) | Mr Nigel Wray |
14,514,130 (6.10%) | FMR LLC and FIL (formerly FMR Corp and FIL) |
Relative to the previous close share price of , Virotec International Limited's (VTI1) current share price of constitutes a movement of or . Virotec International Limited's (VTI1) share price movement is when compared to 7 days ago and is n/a below VTI1's 52-week high of n/a.
Virotec International Limited (VTI1) will release its next Annual Report on n/a. Virotec International Limited's (VTI1) last annual report was released on n/a.
Virotec International Limited (VTI1) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.